| Heartburn pills may harm hips
Q: I saw part of a news story on TV that said people who take Nexium (and similar drugs) for a year or more are at greater risk of bone-density loss and have more bone fractures. I have been taking Nexium for heartburn for almost a year and a half. I have had a knee replacement and a total hip replacement. I did not get the details of who did the study and how. I want to ask my gastroenterologist if I can stop taking Nexium, but I would like to be able to give him some details. Can you supply them? .
Heartburn Pills May Harm Hips QUESTION:
I saw part of a news story on TV that said people who take Nexium (and similar drugs) for a year or more are at greater risk of bone-density loss and have more bone fractures. I have been taking Nexium for heartburn for almost a year and a half. I have had a knee replacement and a total hip replacement. I did not get the details of who did the study and how. I want to ask my gastroenterologist if I can stop taking Nexium, but I would like to be able to give him some details. Can you supply them? Next: The facts > .
AstraZeneca reports strong Q4 earnings, says pipeline needs to be strengthened
LONDON (AP) - AstraZeneca PLC announced it will slash 3,000 jobs over the next three years despite reporting its third successive year of earnings growth Thursday, stressing that it still needs to improve its weak pipeline of future drugs. The drug maker, which is facing patent challenges and escalating generic competition, revealed the job cuts as part of a US$500 million (euro384.02 million) three-year revamp of its supply chain as it said that sales growth would continue at a slower pace this year. Net profit for the three months to Dec. 31 rose 17 per cent to US$1.4 billion (euro1.08 billion), from US$1.2 billion a year earlier, AstraZeneca said. Revenue rose 14 per cent to US$7.2 billion (euro5.56 billion). For the full year, profits rose 28.5 per cent to US$6.04 billion (euro4.66 billion), while revenue lifted 11 per cent to US$26.8 billion (euro20.69 billion), marking the third year of growth since the expiration of a number of key patents in 2003.
Sunman teen fights rare disease
Left untreated the disease is fatal within 60 days. A startling statement made by April Borders brings the reality of the rare disease her son David has into perspective.
As David Madison, 17, of Sunman, was attending classes as a perfectly normal student at East Central, something was taking place on the inside of him that would change his life forever. He had developed Hemophagocytic Lympho Histiocytosis, a disease that allows his white blood cells to come out in an immature form and collect in his organs shutting them down. The disease is fatal if it isnt treated in 60 days, according to Madisons mother, April, who said it affects only one in a million. Thats her boy, one in a million!
Madison starting getting sick in October of 2006 and began to lose a substantial amount of weight.
|
